The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune tumor microenvironnement (iTME) post-neoadjuvant chemotherapy, beyond PD-L1: Novel immune targets in ovarian cancer, data from the CHIVA trial, a GINECO/GINEGEPS study.
 
Felix Blanc-Durand
Consulting or Advisory Role - AstraZeneca (Inst); Eisai
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Elisa Yaniz-Galende
No Relationships to Disclose
 
Catherine Genestie
No Relationships to Disclose
 
Hortense Gauthier De Saint Basile
No Relationships to Disclose
 
Laure Chardin
No Relationships to Disclose
 
Gaetan De Rauglaudre
No Relationships to Disclose
 
Nadia Raban
No Relationships to Disclose
 
Annick Chevalier
No Relationships to Disclose
 
Gwenael Ferron
No Relationships to Disclose
 
Marie-Christine Kaminsky
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; DECIPHERA; Genmab; GlaxoSmithKline; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; BMS; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Roche; Seagen; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES
 
Salima Hamizi
No Relationships to Disclose
 
Pierre Combe
No Relationships to Disclose
 
Sophie Abadie Lacourtoisie
No Relationships to Disclose
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; GlaxoSmithKline; Ipsen; Janssen
 
Jérome Meunier
No Relationships to Disclose
 
Anne Floquet
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Travel, Accommodations, Expenses - Pierre Fabre
 
Jérôme Alexandre
No Relationships to Disclose
 
Audrey Le Formal
No Relationships to Disclose
 
Alexandra Leary
Honoraria - Medscape
Consulting or Advisory Role - AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Tesaro (Inst); zentalis
Research Funding - Inivata (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro